WW International Appoints Former Ookla CEO Stephen Bye as New CEO

WW International has appointed former Ookla CEO Stephen Bye as its new President, CEO, and board member, effective this fall. This leadership transition signals a strategic pivot as the company integrates its traditional behavioral weight management programs with clinical access to GLP-1 medications.

"We are thrilled to welcome Stephen as the CEO of Weight Watchers. He is a proven chief executive and operations expert with a track record of growing subscription businesses, strengthening consumer offerings and creating significant shareholder value," said Gene Davis, Chairman of the Weight Watchers Board of Directors, in a statement.

Leadership Search Criteria

Bye joins the company after serving as President and CEO of connectivity intelligence firm Ookla. His selection follows a targeted search process overseen by the board’s Nominating and Corporate Governance Committee, which sought a candidate with experience in subscription-based models and organizational transformation.

"The Board approached this search with a clear and disciplined set of criteria for the leader we believe Weight Watchers needs at this stage of its evolution. We prioritized proven CEO leadership, deep experience in consumer subscription and product businesses, a track record of leading businesses through periods of significant change, and a demonstrated ability to drive profitable growth and create long-term shareholder value," said Nikolaj Sjoqvist, Chair of the Board’s Nominating and Corporate Governance Committee.

Navigating the GLP-1 Era

The appointment occurs as WW International addresses changes in the weight health market, where the rise of GLP-1 agonists has affected traditional diet-based subscription models. The company’s recent filings indicate a focus on blending its legacy behavioral tools with medical interventions.

"What excites me most is the opportunity to bring together Weight Watchers’ proven behavioral approach, clinical care and access to GLP-1 medications with technology and an increased focus on data-driven results to create a truly integrated and personalized weight health experience," said Stephen Bye in a statement.

The success of this transition depends on whether a technology-focused leader can scale a hybrid service model that bridges the gap between digital behavioral coaching and pharmaceutical weight loss support. The firm continues to evaluate its subscription retention metrics as it repositions its brand within this clinical framework.